Epstein-Barr virus associated lymphoproliferative disorder

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
CAR-T cell therapy 1 substance
Phase III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Pierre Fabre Medicament Commercial
    TABELECLEUCEL
    2024-516622-57-00 5 countries 2020 n=26 Orphan
    Ended

Phase II

1 trial
  • Pierre Fabre Medicament Commercial
    TABELECLEUCEL
    2024-516623-14-00 5 countries 2021 n=64 Orphan
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Pierre Fabre Medicament Commercial 2 Phase II, Phase III 1
New trials by year
2020
1
2021
1
← All indication landscapes